EVELYN THOMPSON: Open Payments
NPI 1750130142 · DEPEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$962 in 43 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $76 · 2025 $962
Food & beverage: $962
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $279 |
| Lilly USA, LLC | 8 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| PFIZER INC. | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| Edwards Lifesciences Corporation | 2 | $58 |
| Abbott Laboratories | 2 | $49 |
| ABBVIE INC. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: Ozempic, MOUNJARO, CAPLYTA, Kerendia, NURTEC ODT, FREESTYLE LIBRE 3, Wegovy, ELIQUIS.
Industry payments across NY — which companies pay providers there.
